Massimo Francalancia
- Co-authors
- Silvia MeschiDaniele LapaGiulia MatusaliAnna Rosa GarbugliaAurora BettiniFrancesca ColavitaFabrizio MaggiGiulia Gramigna
- Topics
- SARS-CoV-2 and COVID-19 Research (5 papers)Bacillus and Francisella bacterial research (4 papers)COVID-19 Clinical Research Studies (4 papers)
- Journals
- International Journal of Molecular SciencesFrontiers in ImmunologyFrontiers in Microbiology
- Partner nations
- ItalyUnited StatesNetherlands
In The Last Decade
Massimo Francalancia
14 papers receiving 88 citations
Peers
Comparison fields: 5 of 45
- Infectious Diseases 49
- Molecular Biology 30
- Epidemiology 20
- Virology 15
- Molecular Medicine 8
Countries citing papers authored by Massimo Francalancia
This map shows the geographic impact of Massimo Francalancia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Francalancia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Francalancia more than expected).
Fields of papers citing papers by Massimo Francalancia
This network shows the impact of papers produced by Massimo Francalancia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Francalancia. The network helps show where Massimo Francalancia may publish in the future.
Co-authorship network of co-authors of Massimo Francalancia
This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Francalancia. A scholar is included among the top collaborators of Massimo Francalancia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Francalancia. Massimo Francalancia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 6 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 12 | |
| 11 | 5 | |
| 12 | 15 | |
| 13 | 13 | |
| 14 | 12 | |
| 15 | 5 |
About Massimo Francalancia
Massimo Francalancia is a scholar working on Virology, Infectious Diseases and Molecular Medicine, having authored 15 papers that have together received 89 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Bacillus and Francisella bacterial research (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Virology (15 citations), Infectious Diseases (49 citations) and Molecular Medicine (8 citations). Massimo Francalancia has collaborated with scholars based in Italy, United States and Netherlands. Frequent co-authors include Silvia Meschi, Daniele Lapa, Giulia Matusali, Anna Rosa Garbuglia, Aurora Bettini, Francesca Colavita, Fabrizio Maggi, Giulia Gramigna, Emanuele Nicastri and Laura Falasca. Their work appears in journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.